Telix Pharmaceuticals is a biopharmaceutical company that develops and commercializes diagnostic and therapeutic radiopharmaceuticals across oncology and medical imaging applications. The company operates three primary business segments: Precision Medicine, which generates revenue from direct sales of FDA-approved diagnostic imaging agents like Illuccix to hospitals, healthcare systems, and imaging centers; Therapeutics, which develops a pipeline of therapeutic radiopharmaceuticals and generates revenue through milestone payments and research services; and Manufacturing Solutions, which operates vertically integrated GMP-certified manufacturing facilities and radiopharmacy operations providing both internal supply and contract manufacturing services to external customers. Telix serves healthcare providers across North America, Asia Pacific, and Europe, with the United States representing its primary market.